Apurva Pandey

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience

Seth A. Wander, Hyo S. Han, Mark L. Zangardi et al. · Journal of the National Comprehensive Cancer Network · 2021 · 85 citations

Medicine, Oncology, Pharmacology +16

Theranostic Gallium Siderophore Ciprofloxacin Conjugate with Broad Spectrum Antibiotic Potency

Apurva Pandey, Chloé Savino, Shin Hye Ahn et al. · Journal of Medicinal Chemistry · 2019 · 81 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +15

Preclinical evaluation and molecular docking of 1,3-benzodioxole propargyl ether derivatives as novel inhibitor for combating the histone deacetylase enzyme in cancer

Neeraj Kumar, Ravi Tomar, Apurva Pandey et al. · Artificial Cells Nanomedicine and Biotechnology · 2017 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Salmochelin S4-Inspired Ciprofloxacin Trojan Horse Conjugate

Thomas J. Sanderson, Conor M. Black, James W. Southwell et al. · ACS Infectious Diseases · 2020 · 45 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +10